Defeat diabetes

We will not allow the success of our company to be defined by the steady increase in the number of people living with serious chronic diseases, like type 2 diabetes and obesity.

We take no pleasure in the suffering and hardships faced by people living with a chronic disease. In some countries, the financial burden of providing or getting access to medical care puts people at risk of serious health complications.

We are committed to helping societies defeat diabetes, and our strategy is clear – accelerate prevention of type 2 diabetes and obesity, and provide access to affordable care for vulnerable patients in every country.

Our success will be defined by the solutions we bring and the health and well-being of the people and communities benefiting from them.

Learn more about our strategy to defeat diabetes.

Pursuing zero environmental impact

We are the first pharmaceutical company to use 100% renewable power in all our global production facilities. We are proud but also motivated to go even further.

With our Circular for Zero strategy, we are starting a journey to achieve zero environmental impact in all our business activities.

We will collaborate proactively with suppliers to reduce the environmental impact across our supply chain, cut CO₂ emissions from all our operations and transportation, and solve the end-of-life product waste challenge to eliminate waste.

Follow our journey to achieve zero impact.

Novo Nordisk A/S products

Growth Hormone Pens

FlexPro PenMate - Pre-Filled Multi-Dose Delivery System

NordiFlex PenMate - Pre-Filled Multi-Dose Delivery System